Detalhe da pesquisa
1.
Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.
Lancet
; 393(10186): 2146-2154, 2019 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31000194
2.
Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis.
Lancet Glob Health
; 7(3): e337-e346, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30784634
3.
Coverage and timeliness of vaccination and the validity of routine estimates: Insights from a vaccine registry in Kenya.
Vaccine
; 36(52): 7965-7974, 2018 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30416017
4.
Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in Kenya.
PLoS One
; 10(10): e0141896, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26509274
5.
Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies.
Lancet Glob Health
; 2(7): e397-405, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25103393
6.
Cohort Profile: The Kilifi Vaccine Monitoring Study.
Int J Epidemiol
; 46(3): 792-792h, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789669